TEL AVIV--Compugen is making a concentrated effort to market its Leads computational biology platform to agricultural biotechnology companies around the world, according to a Compugen executive. The bioinformatics company, headquartered here with offices in the US, has, until now, focused sales strategies in the pharmaceutical market. But by demonstrating the product's effectiveness with Arabidopsis data, Compugen said it is convincing ag biotech companies of the potential uses for Leads in agricultural genomics research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.